Price / Bookn/mnegative shareholder equity, so no book multiple, Q4 FY2026
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Source SEC Filings (10-K/10-Q)Latest period Q4 FY2026, ended Jun 30, 2026ReportedCurrency USDFYE July
Newest figures come from the 10-K for Q4 FY2026, filed Aug 26, 2026.
Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NIMU SEC filings page.
This page shows NON-INVASIVE MONITORG (NIMU) financial statements, including the
income statement, balance sheet, cash flow statement, and key financial ratios.
View 15 years of annual fundamentals and quarterly data, with year-over-year
growth rates and compound annual growth rates (CAGR).
All figures are derived from SEC filings (10-K and 10-Q reports).
Rhea AINIMUFY2025
The reported business mechanic is balance-sheet contraction paired with liabilities expanding faster than the asset base.
From FY2021 to FY2024, recorded assets fell from $59K to $34K while liabilities rose from $299K to $759K. That combination deepened negative equity from -$240K to -$725K, making the financing structure more central than operating scale in the available data.
The available figures show a thin-liquidity structure: current assets remained well below current liabilities, with the current ratio near 0.2x in both FY2021 and FY2024. This indicates limited short-term balance-sheet flexibility even before considering longer-term obligations.
Operating loss narrowed from $158K in FY2021 to $59K in FY2024, but FY2024 still recorded a net loss of $113K. Interest expense reached $54K versus $14K in FY2022, so costs below operations continued to materially affect reported results.
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
Financial health score not available
NON-INVASIVE MONITORG does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
NON-INVASIVE MONITORG reported -$284K in net income in Q4 2026.
EPS (Diluted)
-$0.28
YoY-600.0%
NON-INVASIVE MONITORG earned -$0.28 per diluted share (EPS) in Q4 2026. This represents a decrease of 600.0% from the same quarter a year earlier.
Revenue
Not reported for Q4 2026.
EBITDA
Not reported for Q4 2026.
Cash & Balance Sheet
Cash & Debt
$160K
YoY+5233.3%
QoQ+566.7%
NON-INVASIVE MONITORG held $160K in cash as of Q4 2026; long-term debt is not reported for that period.
Shares Outstanding
1M
NON-INVASIVE MONITORG had 1M shares outstanding in Q4 2026.
Free Cash Flow
Not reported for Q4 2026.
Dividends Per Share
Not reported for Q4 2026.
Margins & Returns
None of these metrics is reported for Q4 2026.
Capital Allocation
None of these metrics is reported for Q4 2026.
NIMU Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Income Tax.
TTM is the trailing twelve months, Q1 FY2026 through Q4 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
NIMU Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Accounts Receivable, Goodwill.
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
NIMU Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q1 FY2026 through Q4 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
NIMU Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: FCF Margin.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$907K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
What is NON-INVASIVE MONITORG's earnings per share (EPS)?
NON-INVASIVE MONITORG (NIMU) reported diluted earnings per share of -$0.21 for fiscal year 2025. This represents a -90.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What are NON-INVASIVE MONITORG's total assets?
NON-INVASIVE MONITORG (NIMU) had $7K in total assets as of fiscal year 2025, including both current and long-term assets.
What is NON-INVASIVE MONITORG's current ratio?
NON-INVASIVE MONITORG (NIMU) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is NON-INVASIVE MONITORG's P/E ratio?
NON-INVASIVE MONITORG (NIMU) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $11.7M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is NON-INVASIVE MONITORG's price-to-sales ratio?
NON-INVASIVE MONITORG (NIMU) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $11.7M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is NON-INVASIVE MONITORG's debt-to-equity ratio negative or not reported?
NON-INVASIVE MONITORG (NIMU) has negative shareholder equity of -$907K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
